568 results
Update on the regulation of high-risk medical devices: a transatlantic perspective
25 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to get an update on new developments in the regulation of high-risk medical devices in Europe and the USA and to learn about opportunities for physicians to become more involved in the regulatory environment.
This session was originally presented during PCR...
Target all comers 3-year results - Evaluation of Cobalt Chrome Rapamycin Drug Eluting Stent
25 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to review the Firehawk family TES technology and early clinical outcomes in the treatment of atherosclerotic lesions, to gain the first sight of the 3-year results of the TARGET AC trial and to look into the Future Directions of Target...
Paclitaxel DCB for coronary lesions: 12-month results. Do drug-coated balloons PREVAIL?
25 Jun 2020 – From PCR e-Course 2020
Consult this abstract to discover the PREVAIL trial results and the implications for drug-coated balloons in percutaneous coronary intervention.
Videos included on this page: the abstract presentation and an Investigator Perspective.
Last frontiers in treatment of high bleeding risk patients
Watch this session if you want to learn from experts the complexity of HBR patients, to discover newest data on DAPT in this population and to get a first-hand update on upcoming major development in DAPT for HBR patients.
Speaker: Davide Capodanno
This interview supported by Terumo was...
Evaluation of PP-ZES vs. PF-AES Stents in PCI: Latest insights from the ReCre8 randomised trial
Watch this interview if you want to understand how strongly safety & efficacy are interconnected in high bleeding risk patients (very complex patients) and how a Safe DES able to have superior Efficacy would optimize the outcome in HBR patients.
Speakers: Gennaro Sardella, Pieter Stella
This interview supported...
The new paradigm for coronary interventions
Watch this session to understand indications for DEB vs. DES & the potential advantage of a sustained sirolimus release when utilised in a DEB, and to get insights into the breakthrough technology of SELUTION SLR & its initial clinical data & clinical experience.
Speakers: Stephan Windecker, Robert...
First-in-human evaluation of a novel sirolimus-eluting ultra-high molecular weight APTITUDE bioresorbable scaffold: 9- and 24-month imaging and clinical results of the RENASCENT II trial
18 Jun 2020
The novel sirolimus-eluting ultra-high molecular weight APTITUDE bioreabsorbable vascular scaffold (BRS) displays higher mechanical strength, expansion capabilities and resistance to fracture compared to other BRS technologies. RENASCENT II is a prospective, multicentre first-in-human clinical study evaluating the clinical performance of the APTITUDE BRS in the treatment...
Authors :
How to treat ostial lesions with Szabo’s technique?
28 May 2020
Szabo’s technique, also known as “tail-wire” technique, is one of the few specific ostial intervention techniques that can be helpful to achieve precise coverage of the ostium without excessive protrusion into the aorta or the respective main vessel... Discover the tips and solutions proposed by Felix...

Author

Author

Author

Author
How to use a guide-extension catheter for stent delivery
15 May 2020
Population ageing is increasing. Therefore extensive coronary artery calcification is a frequent finding and results in complex coronary interventions. Despite the improvement of stent- and balloon- profile, delivery can be challenging due to vessel tortuosity and calcified plaque... Discover the tips and solutions proposed by Lucas...
Author

Author
Impact of kissing balloon in patients treated with ultrathin stents for left main lesions and bifurcations: an analysis from the RAIN-CARDIOGROUP VII study
26 Mar 2020
The objective of this analysis was to investigate the potential benefits of FKI in bifurcations treated with new generation ultrathin stents using a 1- or 2-stent technique.

Reviewer

Reviewer